The US Oncology Network Promotes Leader in Value-Based Care Dr. Marcus Neubauer to Chief Medical Officer

July 17, 2018

Medical oncologist is appointed to spearhead The Network’s significant medical programs and collaborative, integrated approach to cancer care

The Woodlands, Texas (July 17, 2018) — The US Oncology Network (The Network) announced the appointment of Marcus Neubauer, M.D., as its chief medical officer, building on its mission of delivering a comprehensive approach to cancer care. Michael Seiden, M.D., Ph.D. will continue to lead The Network as its president.

Dr. Neubauer has been a practicing medical oncologist for over 20 years, serving previously as a physician and leader in our Kansas City practice. For the past five years he has served as the vice president and medical director for payer, clinical services, and value-based care, working with over 1,400 community oncologists across the country. He is a recognized leader in innovation in clinical pathways, value-based care and contracting and the Center for Medicare and Medicaid Innovation’s (CMMI®) Oncology Care Model.

Dr. Neubauer has served numerous appointments and committees, received honors, awards and has been featured as a thought leader in publications for the past 25 years. While serving The US Oncology Network, he has continued his clinical activities in Seattle as an associate clinical professor for the Seattle Cancer Care Alliance.

“I am thrilled to be continuing my career with The US Oncology Network in this leadership role,” said Dr. Neubauer. “It’s an exciting opportunity for me to help guide The Network’s approach to cancer treatment amid the many changes in the healthcare environment to ensure comprehensive high-quality, value-based care in the community setting.”

Dr. Neubauer has been the lead or contributing author on more than 60 original, peer-reviewed research articles, editorials and meeting abstracts. In addition to his clinical work and medical-director role for The Network, he has served on the Journal of Oncology Practice editorial board for six years and is a current editorial board member for the Community Oncology and Supportive Care Journal since 2012.

“After a national search for a chief medical officer, we are excited to share that our well-respected physician-leader will serve in this forward-thinking role,” said Dr. Michael Seiden. “Dr. Neubauer will work closely with Dr. Lucy Langer, chair of The US Oncology Network national policy board and joins my executive committee effective July 16.”

Dr. Neubauer is a board-certified, fellowship-trained medical oncologist who earned his medical degree and completed his internship and residency at the University of Kansas in Kansas City. He completed his oncology fellowship at the University of Washington in Seattle. Dr. Neubauer will establish residence and office in The Woodlands, TX.

About The US Oncology Network

The US Oncology Network is one of the nation’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. A physician-led organization, The US Oncology Network unites like-minded physicians and clinicians around a common vision of improving patient outcomes and quality of life. Leveraging healthcare information technology, shared best practices, evidence-based guidelines and quality measurements, physicians within The US Oncology Network are pioneering new ways to achieve this vision. The US Oncology Network is committed to strengthening patient access to integrated care in local communities across the nation, including collaboration with a variety of payers, hospitals and academic institutions. The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system. For more information, visit

About McKesson Specialty Health

McKesson Specialty Health, a division of McKesson Corporation, works together with stakeholders across the healthcare delivery system to preserve and strengthen specialty care, passionately driven by the benefits it provides patients and the system as a whole. Through innovative provider, practice management, biopharma and payer solutions, McKesson Specialty Health focuses on improving the financial, operational and business health of our customers and partners so they may provide the best care to patients. At McKesson Specialty Health, we believe that we are all in this together. For more information, visit

Public Relations Contact